• I Executive summary (English)
  • 1 Introduction
  • 2 Evaluation of the Council Recommendation on harm reduction
  • 3 Conclusions and suggestions for follow up
  • II Résumé analytique (Français)
  • 1 Introduction
  • 2 Evaluation de la Recommandation du Conseil sur la réductiondes méfaits
  • 3 Conclusions et suggestions de suivi
  • III Kurzfassung (Deutsch)
  • 1 Einleitung
  • 2 Evaluierung der Empfehlung des Rates zu Schadensminimierung
  • 3 Schlussfolgerungen und Vorschläge für weiteres Vorgehen
  • IV Summary (Main report short version)
  • 1 Objectives and methods
  • 2 Epidemiological situation
  • 3 Effectiveness of interventions
  • 4 Implementation of CR 1
  • 5 Implementation of CR 2
  • 6 Implementation of CR 3
  • 7 Conclusions and recommendations
  • V Acknowledgements
  • VI Main Report - long version
  • 8 Introduction
  • 8.1 Project objectives
  • 9 Methods
  • 9.1 Analysis of data available at the EMCDDA
  • 9.2 Gap-survey
  • 9.3 Policy maker survey
  • 9.4 Consultation of stakeholders
  • 9.5 Review of literature
  • 9.6 Limitations
  • 10 Effectiveness of interventions
  • 11 Epidemiological situation concerning drug-related harm in the EU and candidate/acceding countries
  • 12 Situation concerning supply of harm reduction in the EU andcandidate/acceding countries
  • 13 Modelling the relation between harm reduction measures and drug-related harm in the EU and candidate/acceding countries
  • 14 Conclusions and recommendations
  • 15 Council Recommendation of 18 June 2003 on the prevention andreduction of health-related harm associated with drug dependence(2003/ 488/ EC)
  • Abbreviations
  • Literature